Evolution of the Average Target: BlossomHill Therapeutics, Inc.

Evolution of the Average Target - BlossomHill Therapeutics, Inc.

Evolution of the Target Price: BlossomHill Therapeutics, Inc.

Evolution of the Target Price - BlossomHill Therapeutics, Inc.

Changes in Analyst Recommendations: BlossomHill Therapeutics, Inc.

450b2834ff7.ikVEhQO6i3rV6bGG-VNBYF5rHTA2jlmj1-0YcuJw_pw.7AEiwDPd7RmwkYi2sWM1KSsSfkZb6mmbuq9eMJECzNfrDAzxe__uS-a48A~efece09d4c67f416dfbcd34b520a7d48

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +136.32%
+24.19%
+33.33%
+14.65%
+10.55%
+36.95%
+16.48%
+47.08%
+22.87%
+29.34%
Average +37.18%
Weighted average by Cap. +25.31%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.98USD
Average target price
35.40USD
Spread / Average Target
+136.32%
High Price Target
40.00USD
Spread / Highest target
+167.02%
Low Price Target
30.00USD
Spread / Lowest Target
+100.27%

Analyst Consensus Detail

Analyst consensus - BlossomHill Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BlossomHill Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. BLSM Stock
  4. Consensus BlossomHill Therapeutics, Inc.